Abrdn PLC Codexis, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Abrdn PLC holds 4,200,950 shares of CDXS stock, worth $10.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,200,950
Previous 606,294
592.89%
Holding current value
$10.3 Million
Previous $1.63 Million
528.83%
% of portfolio
0.02%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CDXS
# of Institutions
130Shares Held
69.2MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$30.7 Million7.35% of portfolio
-
Casdin Capital, LLC New York, NY7.2MShares$17.6 Million2.46% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.59MShares$11.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$9.83 Million0.43% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $160M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...